— Know what they know.
Not Investment Advice
Also trades as: 0J9P.L (LSE) · $vol 0M

INCY NASDAQ

Incyte Corporation
1W: -0.2% 1M: +0.7% 3M: -3.9% YTD: -4.0% 1Y: +49.2% 3Y: +50.6% 5Y: +17.9%
$97.16
-0.25 (-0.26%)
 
Weekly Expected Move ±3.7%
$88 $92 $95 $99 $102
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 55 · $19.4B mcap · 198M float · 0.766% daily turnover · Short 64% of daily vol

Cash Flow Trends

Operating Cash Flow
$1.4B +321.5% ▲
Capital Expenditures
$59M +31.8% ▲
5Y CAGR: -20.7%
Free Cash Flow
$1.4B +443.9% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$19M +99.0% ▲
Net Change in Cash
$1.4B +192.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$949M$341M$598M$33M$1.3B
Depreciation & Amort.$58M$68M$83M$89M$93M
Stock-Based Comp.$183M$188M$216M$266M$249M
Change in Working Capital-$15M$199M-$249M$138M-$527M
Other Non-Cash Items$40M$117M$8M-$105M$64M
Operating Cash Flow$749M$970M$496M$335M$1.4B
— Investing Activities —
Capital Expenditures-$181M-$78M-$47M-$86M-$59M
Acquisitions (Net)$181M$709K$47M$0$0
Investment Purchases-$269M-$80M-$466M-$258M-$303M
Investment Sales$242M$79M$306M$516M$285M
Other Investing-$181M-$709K-$47M-$14M-$25M
Investing Cash Flow-$208M-$79M-$208M$158M-$103M
— Financing Activities —
Net Debt Issuance-$2M-$3M-$3M-$4M-$5M
Stock Repurchased$0$0$0-$2.0B-$19M
Dividends Paid$0$0$0$0$0
Other Financing-$50M-$59M-$53M-$13M-$97M
Financing Cash Flow$6M-$794K-$20M-$2.0B$101M
Net Change in Cash$544M$894M$262M-$1.5B$1.4B
Cash End of Period$2.1B$3.0B$3.2B$1.7B$3.1B
Free Cash Flow$568M$892M$449M$249M$1.4B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms